(Q44359291)

English

Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates

scientific article published in March 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates (English)

1 reference

Europe PubMed Central

2 December 2017

Paget's disease of bone

1 reference

based on heuristic

inferred from title

author name string

Alvarez L

1

1 reference

Europe PubMed Central

2 December 2017

Peris P

2

1 reference

Europe PubMed Central

2 December 2017

Guañabens N

3

1 reference

Europe PubMed Central

2 December 2017

Vidal S

4

1 reference

Europe PubMed Central

2 December 2017

Ros I

5

1 reference

Europe PubMed Central

2 December 2017

Pons F

6

1 reference

Europe PubMed Central

2 December 2017

Filella X

7

1 reference

Europe PubMed Central

2 December 2017

Monegal A

8

1 reference

Europe PubMed Central

2 December 2017

Muñoz-Gomez J

9

1 reference

Europe PubMed Central

2 December 2017

Ballesta AM

10

1 reference

Europe PubMed Central

2 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 March 2003

1 reference

Europe PubMed Central

2 December 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

2 December 2017

48

1 reference

Europe PubMed Central

2 December 2017

824-828

1 reference

Europe PubMed Central

2 December 2017

3

1 reference

Europe PubMed Central

2 December 2017

Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone

1 reference

https://api.crossref.org/works/10.1002%2FART.10834

21 January 2018

Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption.

1 reference

https://api.crossref.org/works/10.1002%2FART.10834

21 January 2018

Osteoprotegerin deficiency and juvenile Paget's disease.

1 reference

https://api.crossref.org/works/10.1002%2FART.10834

21 January 2018

Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone

1 reference

https://api.crossref.org/works/10.1002%2FART.10834

21 January 2018

Evaluation of the role of RANK and OPG genes in Paget's disease of bone

1 reference

https://api.crossref.org/works/10.1002%2FART.10834

21 January 2018

Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1002%2FART.10834

21 January 2018

Usefulness of biochemical markers of bone turnover in assessing response to the treatment of Paget's disease

1 reference

https://api.crossref.org/works/10.1002%2FART.10834

21 January 2018

Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL.

1 reference

https://api.crossref.org/works/10.1002%2FART.10834

21 January 2018

Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone

1 reference

https://api.crossref.org/works/10.1002%2FART.10834

21 January 2018

Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.

1 reference

https://api.crossref.org/works/10.1002%2FART.10834

21 January 2018

Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line

1 reference

https://api.crossref.org/works/10.1002%2FART.10834

21 January 2018

The ratio of messenger RNA levels of receptor activator of nuclear factor kappaB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.10834

21 January 2018

Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines

1 reference

https://api.crossref.org/works/10.1002%2FART.10834

21 January 2018

Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity

1 reference

https://api.crossref.org/works/10.1002%2FART.10834

21 January 2018

Identifiers

10.1002/ART.10834

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44359291&oldid=2019780121"